Erythema, local pain & induration, thrombophlebitis, allergic reactions, GI & haematological disturbances, pseudomembranous colitis, increase in liver enzymes, myoclonic activity, hallucinations, confusional states, seizures, paresthesia, encaphalopathy, agitation, dyskinesia, hearing loss, taste perversion. Drug-related nausea &/or vomiting occur more frequently in granulocytopenic patients.